Literature DB >> 33524424

Impact of COVID-19 preventive measures on other infectious and non-infectious respiratory diseases in Pakistan.

Muhammad Suleman Rana1, Muhammad Usman2, Muhammad Masroor Alam2, Aamer Ikram2, Muhammad Salman2, Syed Sohail Zahoor Zaidi2, Massab Umair2, Mehmood Qadir2.   

Abstract

Entities:  

Year:  2021        PMID: 33524424      PMCID: PMC7845518          DOI: 10.1016/j.jinf.2021.01.018

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


× No keyword cloud information.
Dear Editor, We read with immense interest the article entitled “The impact of COVID-19 preventive measures on airborne/droplet- transmitted infectious diseases in Taiwan” by Shey-Ying Chen et al. Which reported the decline in other respiratory diseases in Taiwan and here we would like to present the unintended decline in communicable and non-communicable respiratory illnesses in Pakistan. COVID-19 pandemic is now becomes a worldwide public health disaster and as of January 22, 2021, there are more than 98 million confirmed coronavirus cases including over 2 million deaths have been reported across the globe. In Pakistan as of 22 January 2021, the toll of confirmed SARS-COV-2 cases reached 528,891 including 11,204 deaths after its first laboratory confirmation on 26 February 2020. The collateral damage due to co-infection of COVID-19 with other respiratory pathogens and collateral benefits due to the implementation of COVID-19 preventative measures has been reported in the recent studies.3, 4 The present study was conducted to investigate the positive impact of COVID-19 preventative measures on other infectious and non-infectious respiratory diseases in Pakistan. The data source utilized for the present study is based on the surveillance records available at National Institute of Health (NIH) Islamabad, which is the national public health institute supporting disease surveillance and epidemiology programs across the country. For the non-infectious respiratory diseases the data was obtained from the chest care clinic Islamabad. For comparative analysis we extracted the number of cases reported between January to December 2019 and 2020. Twelve infectious diseases including Tuberculosis (TB), Measles, Rubella, Influenza, Respiratory Syncytial Virus (RSV), Pertussis, Diphtheria, Epstein bar virus (EBV), Pneumonia, Haemophilus influenzae, Varicella zoster virus (VZV) and Mumps are notifiable diseases in Pakistan, for which the case investigation and reporting is mandatory for all public and private hospitals. Overall the number of 12 infectious and 5 non-infectious respiratory diseases declined from 1,92,026 in 2019 to 91,576 in 2020, with the reduction of 52.3% (Table 1 ). Comparatively more than 80% decline in 8 infectious diseases including, Rubella, RSV, Pertussis, Diphtheria, EBV, Pneumonia, Haemophilus influenzae Mumps and 5 non-infectious respiratory diseases such as Bronchiolitis, Asthma, Cystic fibrosis, Bronchitis and Bronchiectasis was observed in Pakistan. According to the data of chest care clinic Islamabad, for non-infectious respiratory diseases no any critical case is reported during 2020 as compare to the multiple critical cases were reported during 2019.
Table 1

Number of cases of infectious and noninfectious respiratory diseases reported during January to December in 2019 and 2020.

Diseases20192020% Change
Communicable
 TB17876787358-51.1
 Measles65363253-50.2
 Rubella1488132-91.1
 Influenza41787-79.1
 RSV32021-93.4
 Pertussis62435-94.3
 Diphtheria832157-81.1
 EBV7311-84.9
 Pneumonia1302248-80.9
 Haemophilus Influenzae20937-82.2
 VZV523114-78.2
 Mumps25839-84.9
Non-Communicable
 Bronchiolitis977-92.8
 Asthma41359-85.7
 Cystic Fibrosis413-92.7
 Bronchitis7913-83.5
 Bronchiectasis472-95.7
 Total19202691576-52.3

TB: Tuberculosis, RSV: Respiratory syncytial virus, EBV: Epstein bar virus, VZV: Varicella zoster virus

Number of cases of infectious and noninfectious respiratory diseases reported during January to December in 2019 and 2020. TB: Tuberculosis, RSV: Respiratory syncytial virus, EBV: Epstein bar virus, VZV: Varicella zoster virus The similar trends of unintended decline in other respiratory infectious diseases has already been reported from other countries such as Taiwan, Singapore, and China.5, 6, 7, 8, 9, 10 Results of our study showed that the nationwide use of face mask, regular hand washing, use of sanitizers, social distancing, closure of Malls, schools, colleges, universities, bane on public gathering, massive temperature check, lockdown, extensive testing and quarantine, dramatically reduce the risk of other respiratory diseases. The use of mask is proved to be helpful not only for infectious but also for the prevention of non-infectious respiratory diseases. The government and health authorities should continue to motivate the general public to actively participate in COVID-19 control measures, which will be more helpful to contain COVID-19 and additionally reduce the overall burden of other communicable diseases. During the COVID-19 pandemic the unintended decline in other infectious diseases definitely provide more capacity to deal with COVID-19 containment. The under–reporting of other infectious diseases during the COVID-19 pandemic need further evaluation.

Authors contributions

MSR, AI, MMA, MU, MS and SSZZ conceived and designed the study. MSR, MU, MMA were responsible for data collection and analysis. MSR, MU and MMA wrote the manuscript draft.

Declaration of Competing Interest

All author declared that there is no conflict of interest
  7 in total

1.  The impact of COVID-19 on the diagnosis of TB in Taiwan.

Authors:  J-L Fang; C-M Chao; H-J Tang
Journal:  Int J Tuberc Lung Dis       Date:  2020-12-01       Impact factor: 2.373

2.  COVID-19 preventive measures showing an unintended decline in infectious diseases in Taiwan.

Authors:  Cooper J Galvin; Yu-Chuan Jack Li; Shwetambara Malwade; Shabbir Syed-Abdul
Journal:  Int J Infect Dis       Date:  2020-06-23       Impact factor: 3.623

3.  Decline in invasive pneumococcus diseases while combating the COVID-19 pandemic in Taiwan.

Authors:  Jong-Rung Tsai; Chih-Jen Yang; Wei-Ling Huang; Yen-Hsu Chen
Journal:  Kaohsiung J Med Sci       Date:  2020-05-26       Impact factor: 2.744

4.  Positive effects of COVID-19 control measures on pneumonia prevention.

Authors:  Di Wu; Jianyun Lu; Lan Cao; Xiaowei Ma; Qun Liu; Yanhui Liu; Zhoubin Zhang
Journal:  Int J Infect Dis       Date:  2020-05-26       Impact factor: 3.623

5.  The COVID-19 pandemic and tuberculosis in Taiwan.

Authors:  Chih-Cheng Lai; Weng-Liang Yu
Journal:  J Infect       Date:  2020-06-11       Impact factor: 6.072

6.  Decreased Influenza Incidence under COVID-19 Control Measures, Singapore.

Authors:  Roy Jiunn Jye Soo; Calvin J Chiew; Stefan Ma; Rachael Pung; Vernon Lee
Journal:  Emerg Infect Dis       Date:  2020-04-27       Impact factor: 6.883

7.  Disparities in the excess risk of mortality in the first wave of COVID-19: Cross sectional study of the English sentinel network.

Authors:  Simon de Lusignan; Mark Joy; Jason Oke; Dylan McGagh; Brian Nicholson; James Sheppard; Oluwafunmi Akinyemi; Gayatri Amirthalingam; Kevin Brown; Rachel Byford; Gavin Dabrera; Else Krajenbrink; Harshana Liyanage; Jamie LopezBernal; Cecilia Okusi; Mary Ramsay; Julian Sherlock; Mary Sinnathamby; Ruby S M Tsang; Victoria Tzortziou Brown; John Williams; Maria Zambon; Filipa Ferreira; Gary Howsam; F D Richard Hobbs
Journal:  J Infect       Date:  2020-08-25       Impact factor: 6.072

  7 in total
  7 in total

1.  Changes in Temporal Properties of Notifiable Infectious Disease Epidemics in China During the COVID-19 Pandemic: Population-Based Surveillance Study.

Authors:  Xixi Zhao; Meijia Li; Naem Haihambo; Jianhua Jin; Yimeng Zeng; Jinyi Qiu; Mingrou Guo; Yuyao Zhu; Zhirui Li; Jiaxin Liu; Jiayi Teng; Sixiao Li; Ya-Nan Zhao; Yanxiang Cao; Xuemei Wang; Yaqiong Li; Michel Gao; Xiaoyang Feng; Chuanliang Han
Journal:  JMIR Public Health Surveill       Date:  2022-06-23

2.  Remote Versus In-person Outpatient Clinic Visits and Antibiotic Use Among Children During the COVID-19 Pandemic.

Authors:  Dana Danino; Shalom Ben-Shimol; Amir Sharf; David Greenberg; Noga Givon-Lavi
Journal:  Pediatr Infect Dis J       Date:  2022-07-13       Impact factor: 3.806

3.  Disproportionate reduction in respiratory vs. non-respiratory outpatient clinic visits and antibiotic use in children during the COVID-19 pandemic.

Authors:  Noga Givon-Lavi; Dana Danino; Bart Adriaan van der Beek; Amir Sharf; David Greenberg; Shalom Ben-Shimol
Journal:  BMC Pediatr       Date:  2022-05-06       Impact factor: 2.567

4.  The Importance of Behavioral and Native Factors on COVID-19 Infection and Severity: Insights from a Preliminary Cross-Sectional Study.

Authors:  Hani Amir Aouissi; Mohamed Seif Allah Kechebar; Mostefa Ababsa; Rabih Roufayel; Bilel Neji; Alexandru-Ionut Petrisor; Ahmed Hamimes; Loïc Epelboin; Norio Ohmagari
Journal:  Healthcare (Basel)       Date:  2022-07-19

5.  Respiratory viruses in rural Zambia before and during the COVID-19 pandemic.

Authors:  Gideon Loevinsohn; Mutinta Hamahuwa; Justin Hardick; Pamela Sinywimaanzi; Katherine Z J Fenstermacher; Passwell Munachoonga; Austin Weynand; Mwaka Monze; Yukari C Manabe; Charlotte A Gaydos; Richard E Rothman; Andrew Pekosz; Philip E Thuma; Edgar Simulundu; Catherine G Sutcliffe
Journal:  Trop Med Int Health       Date:  2022-06-08       Impact factor: 3.918

6.  Collateral Impact of COVID-19 Prevention Measures on Re-Emergence of Scarlet Fever and Pertussis in Mainland China and Hong Kong China.

Authors:  Yiran He; Chenjin Ma; Xiangyu Guo; Jinren Pan; Wangli Xu; Shelan Liu
Journal:  Int J Environ Res Public Health       Date:  2022-08-11       Impact factor: 4.614

Review 7.  Effects of COVID-19 prevention procedures on other common infections: a systematic review.

Authors:  Omid Dadras; Seyed Ahmad Seyed Alinaghi; Amirali Karimi; Mehrzad MohsseniPour; Alireza Barzegary; Farzin Vahedi; Zahra Pashaei; Pegah Mirzapour; Amirata Fakhfouri; Ghazal Zargari; Solmaz Saeidi; Hengameh Mojdeganlou; Hajar Badri; Kowsar Qaderi; Farzane Behnezhad; Esmaeil Mehraeen
Journal:  Eur J Med Res       Date:  2021-07-03       Impact factor: 2.175

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.